Future directions in the frontline management of Waldenström macroglobulinemia Review

  

Authors:	Buske, C.; Palomba, M. L.
Review Title:	Future directions in the frontline management of Waldenström macroglobulinemia
Keywords:	treatment outcome; treatment response; review; drug efficacy; rituximab; treatment indication; quality of life; waldenstroem macroglobulinemia; cancer resistance; cost effectiveness analysis; cancer regression; comorbidity; myeloid differentiation factor 88; chemokine receptor cxcr4; front-line; chemoimmunotherapy; waldenstrom macroglobulinemia; asymptomatic disease; ibrutinib; humans; human; waldenstrom's macroglobulinemia; ixazomib; venetoclax; zanubrutinib; pirtobrutinib; treatment-naïve; btk-inhibitors
Journal Title:	Hematology/Oncology Clinics of North America
Volume:	37
Issue:	4
ISSN:	0889-8588
Publisher:	Elsevier Inc.
Date Published:	2023-08-01
Start Page:	719
End Page:	725
Language:	English
DOI:	10.1016/j.hoc.2023.05.001
PUBMED:	37270384
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85163429038&doi=10.1016%2fj.hoc.2023.05.001&partnerID=40&md5=835e0ff9a1262050efe93e6f9a343721
Notes:	Review -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/208028